|
Risk Factors
Citations 451-460 of 1547 total displayed.
|
Past content
(since Jan 1999):
|
- Coronary Heart Disease
Adiponectin and Coronary Heart Disease: A Prospective Study and Meta-Analysis
- Naveed Sattar, Goya Wannamethee, Nadeem Sarwar, Julia Tchernova, Lynne Cherry, A. Michael Wallace, John Danesh, and Peter H. Whincup
Circulation 2006;114:623-629; published online before print as doi:10.1161/CIRCULATIONAHA.106.618918
[Abstract]
[Full text]
- Articles
Adiponectin and Coronary Heart Disease. A Prospective Study and Meta-Analysis
- Naveed Sattar, Goya Wannamethee, Nadeem Sarwar, Julia Tchernova, Lynne Cherry, A. Michael Wallace, John Danesh, and Peter H. Whincup
Circulation published August 7, 2006, doi:10.1161/CIRCULATIONAHA.106.618918
[Abstract]
- Clinician Update
C-Reactive Protein as a Risk Predictor: Do Race/Ethnicity and Gender Make a Difference?
- Michelle A. Albert and Paul M Ridker
Circulation 2006;114:e67-74e, doi:10.1161/CIRCULATIONAHA.106.613570
[Full text]
- Correspondence
Letter by Schmermund and Erbel Regarding Article, "Coronary Artery Calcium: Should We Rely on This Surrogate Marker?"
- Axel Schmermund and Raimund Erbel
Circulation 2006;114:e82, doi:10.1161/CIRCULATIONAHA.106.617829
[Full text]
- Correspondence
Response to Letter Regarding Article, "Coronary Artery Calcium: Should We Rely on This Surrogate Marker?"
- Rita F. Redberg
Circulation 2006;114:e83, doi:10.1161/CIRCULATIONAHA.106.633867
[Full text]
- Issue Highlights
Issue Highlights
-
Circulation 2006;114:359
[Full text]
- Clinician Update
Intravascular Ultrasound in Cardiovascular Medicine
- Stephen J. Nicholls, E. Murat Tuzcu, Ilke Sipahi, Paul Schoenhagen, and Steven E. Nissen
Circulation 2006;114:e55-59e, doi:10.1161/CIRCULATIONAHA.106.637942
[Full text]
- Correspondence
Letter by Powers et al Regarding Article, "Riboflavin Lowers Homocysteine in Individuals Homozygous for the MTHFR 677C T Polymorphism"
- Hilary J. Powers, Ian F.W. McDowell, and Stuart J. Moat
Circulation 2006;114:e65, doi:10.1161/CIRCULATIONAHA.106.613299
[Full text]
- Coronary Heart Disease
Clinical Relevance of C-Reactive Protein During Follow-Up of Patients With Acute Coronary Syndromes in the Aggrastat-to-Zocor Trial
- David A. Morrow, James A. de Lemos, Marc S. Sabatine, Stephen D. Wiviott, Michael A. Blazing, Amy Shui, Nader Rifai, Robert M. Califf, and Eugene Braunwald
Circulation 2006;114:281-288; published online before print as doi:10.1161/CIRCULATIONAHA.106.628909
[Abstract]
[Full text]
- Editorials
Risk Stratification in Secondary Prevention: Advances in Multimarker Profiles, or Back to Basics?
- Caroline Kistorp
Circulation 2006;114:184-186, doi:10.1161/CIRCULATIONAHA.106.639732
[Full text]
|
|
